DailyNewsQuiz
Home
About
FAQ
← Home
business
Feb 08
Genentech multiple sclerosis candidate fenebrutinib meets goal in late-stage trial
AI-Generated from
Seeking Alpha
1.
What is the main topic of the news summary?
A
Diabetes treatment
B
Multiple sclerosis candidate
C
Cancer research
D
Heart disease drug
2.
Which company developed the multiple sclerosis candidate fenebrutinib?
A
Pfizer
B
Merck
C
Genentech
D
Novartis
3.
In which stage of the trial did fenebrutinib meet its goal?
A
Early-stage trial
B
Mid-stage trial
C
Late-stage trial
D
Post-trial analysis
4.
What is the name of the multiple sclerosis candidate mentioned in the news?
A
Fenebrutinib
B
Rituximab
C
Ocrelizumab
D
Natalizumab
5.
Which disease did fenebrutinib target in the trial?
A
Alzheimer's
B
Multiple sclerosis
C
Parkinson's
D
ALS
Submit Answers